2020 ICD-10-CM Diagnosis Code D06

Carcinoma in situ of cervix uteri

    2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
  • D06 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • The 2020 edition of ICD-10-CM D06 became effective on October 1, 2019.
  • This is the American ICD-10-CM version of D06 - other international versions of ICD-10 D06 may differ.
Type 1 Excludes
Type 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as D06. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • cervical intraepithelial neoplasia II [CIN II] (
    ICD-10-CM Diagnosis Code N87.1

    Moderate cervical dysplasia

      2016 2017 2018 2019 2020 Billable/Specific Code
    Applicable To
    • Cervical intraepithelial neoplasia II [CIN II]
    N87.1
    )
  • cytologic evidence of malignancy of cervix without histologic confirmation (
    ICD-10-CM Diagnosis Code R87.614

    Cytologic evidence of malignancy on smear of cervix

      2016 2017 2018 2019 2020 Billable/Specific Code
    R87.614
    )
  • high grade squamous intraepithelial lesion (HGSIL) of cervix (
    ICD-10-CM Diagnosis Code R87.613

    High grade squamous intraepithelial lesion on cytologic smear of cervix (HGSIL)

      2016 2017 2018 2019 2020 Billable/Specific Code
    R87.613
    )
  • melanoma in situ of cervix (
    ICD-10-CM Diagnosis Code D03.5

    Melanoma in situ of trunk

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    D03.5
    )
  • moderate cervical dysplasia (
    ICD-10-CM Diagnosis Code N87.1

    Moderate cervical dysplasia

      2016 2017 2018 2019 2020 Billable/Specific Code
    Applicable To
    • Cervical intraepithelial neoplasia II [CIN II]
    N87.1
    )
Includes
Includes Help
"Includes" further defines, or give examples of, the content of the code or category.
  • cervical adenocarcinoma in situ
  • cervical intraepithelial glandular neoplasia
  • cervical intraepithelial neoplasia III [CIN III]
  • severe dysplasia of cervix uteri
The following code(s) above D06 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to D06:
  • C00-D49
    2020 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
  • D00-D09
    2020 ICD-10-CM Range D00-D09

    In situ neoplasms

    Includes
    • Bowen's disease
    • erythroplasia
    • grade III intraepithelial neoplasia
    • Queyrat's erythroplasia
    In situ neoplasms
Clinical Information
  • Stage 0 includes: (tis, n0, m0). Tis: carcinoma in situ. N0: no regional lymph node metastasis. M0: no distant metastasis. (ajcc 6th ed.)
  • Stage 0 includes: (tis, n0, m0). Tis: carcinoma in situ. N0: no regional lymph node metastasis. M0: no distant metastasis. Figo no longer includes stage 0. (ajcc 7th ed.)
Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
Code annotations containing back-references to D06:
  • Type 1 Excludes: R87.61
    , R87.61
    , R87.61
    , R87.7
    , R87.7
    , N87
    , N87
    , N87
    , C53
    ICD-10-CM Diagnosis Code R87.61

    Abnormal cytological findings in specimens from cervix uteri

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal cytological findings in specimens from other female genital organs (R87.69)
    • abnormal cytological findings in specimens from vagina (R87.62-)
    • carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
    • cervical intraepithelial neoplasia I [CIN I] (N87.0)
    • cervical intraepithelial neoplasia II [CIN II] (N87.1)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
    • severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
    Type 2 Excludes
    • cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
    • cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)
    ICD-10-CM Diagnosis Code R87.61

    Abnormal cytological findings in specimens from cervix uteri

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal cytological findings in specimens from other female genital organs (R87.69)
    • abnormal cytological findings in specimens from vagina (R87.62-)
    • carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
    • cervical intraepithelial neoplasia I [CIN I] (N87.0)
    • cervical intraepithelial neoplasia II [CIN II] (N87.1)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
    • severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
    Type 2 Excludes
    • cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
    • cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)
    ICD-10-CM Diagnosis Code R87.61

    Abnormal cytological findings in specimens from cervix uteri

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal cytological findings in specimens from other female genital organs (R87.69)
    • abnormal cytological findings in specimens from vagina (R87.62-)
    • carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
    • cervical intraepithelial neoplasia I [CIN I] (N87.0)
    • cervical intraepithelial neoplasia II [CIN II] (N87.1)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
    • severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
    Type 2 Excludes
    • cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
    • cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)
    ICD-10-CM Diagnosis Code R87.7

    Abnormal histological findings in specimens from female genital organs

      2016 2017 2018 2019 2020 Billable/Specific Code
    Type 1 Excludes
    • carcinoma in situ (histologically confirmed) of female genital organs (D06-D07.3)
    • cervical intraepithelial neoplasia I [CIN I] (N87.0)
    • cervical intraepithelial neoplasia II [CIN II] (N87.1)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
    • dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
    • vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
    • vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
    • vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
    • severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
    • severe dysplasia of vagina (histologically confirmed) (D07.2)
    ICD-10-CM Diagnosis Code R87.7

    Abnormal histological findings in specimens from female genital organs

      2016 2017 2018 2019 2020 Billable/Specific Code
    Type 1 Excludes
    • carcinoma in situ (histologically confirmed) of female genital organs (D06-D07.3)
    • cervical intraepithelial neoplasia I [CIN I] (N87.0)
    • cervical intraepithelial neoplasia II [CIN II] (N87.1)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
    • dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
    • vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
    • vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
    • vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
    • severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
    • severe dysplasia of vagina (histologically confirmed) (D07.2)
    ICD-10-CM Diagnosis Code N87

    Dysplasia of cervix uteri

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal results from cervical cytologic examination without histologic confirmation (R87.61-)
    • carcinoma in situ of cervix uteri (D06.-)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • HGSIL of cervix (R87.613)
    • severe dysplasia of cervix uteri (D06.-)
    ICD-10-CM Diagnosis Code N87

    Dysplasia of cervix uteri

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal results from cervical cytologic examination without histologic confirmation (R87.61-)
    • carcinoma in situ of cervix uteri (D06.-)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • HGSIL of cervix (R87.613)
    • severe dysplasia of cervix uteri (D06.-)
    ICD-10-CM Diagnosis Code N87

    Dysplasia of cervix uteri

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal results from cervical cytologic examination without histologic confirmation (R87.61-)
    • carcinoma in situ of cervix uteri (D06.-)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • HGSIL of cervix (R87.613)
    • severe dysplasia of cervix uteri (D06.-)
    ICD-10-CM Diagnosis Code C53

    Malignant neoplasm of cervix uteri

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • carcinoma in situ of cervix uteri (D06.-)
  • Applicable To: Z86.001
    ICD-10-CM Diagnosis Code Z86.001

    Personal history of in-situ neoplasm of cervix uteri

      2016 2017 2018 2019 2020 Billable/Specific Code POA Exempt
    Applicable To
    • Conditions classifiable to D06
    • Personal history of cervical intraepithelial neoplasia III [CIN III]
ICD-10-CM Codes Adjacent To D06
D05.11 Intraductal carcinoma in situ of right breast
D05.12 Intraductal carcinoma in situ of left breast
D05.8 Other specified type of carcinoma in situ of breast
D05.80 Other specified type of carcinoma in situ of unspecified breast
D05.81 Other specified type of carcinoma in situ of right breast
D05.82 Other specified type of carcinoma in situ of left breast
D05.9 Unspecified type of carcinoma in situ of breast
D05.90 Unspecified type of carcinoma in situ of unspecified breast
D05.91 Unspecified type of carcinoma in situ of right breast
D05.92 Unspecified type of carcinoma in situ of left breast
D06 Carcinoma in situ of cervix uteri
D06.0 Carcinoma in situ of endocervix
D06.1 Carcinoma in situ of exocervix
D06.7 Carcinoma in situ of other parts of cervix
D06.9 Carcinoma in situ of cervix, unspecified
D07 Carcinoma in situ of other and unspecified genital organs
D07.0 Carcinoma in situ of endometrium
D07.1 Carcinoma in situ of vulva
D07.2 Carcinoma in situ of vagina
D07.3 Carcinoma in situ of other and unspecified female genital organs
D07.30 Carcinoma in situ of unspecified female genital organs

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.